Indivior Pharmaceuticals (INDV) Operating Expenses (2024 - 2026)
Indivior Pharmaceuticals' Operating Expenses was $134 million in Q2 2026, down 25.1% from $179 million a year earlier and down 3.6% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Operating Expenses (2024 - 2026) Analysis & Trends
On a trailing twelve-month basis, Indivior Pharmaceuticals' Operating Expenses was $671 million through Jun 30, 2026, down 10.1% year-over-year; for FY2025, it was $732 million, down 20.3% from FY2024.
- Operating Expenses shows a four-year compound annual growth rate of 11.0% (FY2021 to FY2025).
- In earlier years, Operating Expenses was $919 million in FY2024 (-14.3%), $1.07 billion in FY2023 (+29.6%), $827 million in FY2022 (+71.2%) and $483 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Operating Expenses in data going back to Q1 2024.
- Compared with a year earlier, Operating Expenses was higher in 1 of the last six quarters, with an average decline of 16.4%.
- Per Business Quant data, INDV's Operating Expenses in the three quarters before Q2 2026 was $139 million (Q1 2026), $211 million (Q4 2025) and $187 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -9.70 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.09 Bn |
| 10 | Indivior Pharmaceuticals | 4.35 Bn | 3.32 Bn | 294.00 Mn | 134.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 134.00 Mn |
| Mar 31, 2026 | 139.00 Mn |
| Dec 31, 2025 | 211.00 Mn |
| Sep 30, 2025 | 187.00 Mn |
| Jun 30, 2025 | 179.00 Mn |
| Mar 31, 2025 | 156.00 Mn |
| Dec 31, 2024 | 205.00 Mn |
| Sep 30, 2024 | 206.00 Mn |
| Jun 30, 2024 | 338.00 Mn |
| Mar 31, 2024 | 171.00 Mn |
API Access
Indivior Pharmaceuticals Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();